IA
DYN icon

IFP Advisors’s Dyne Therapeutics DYN Stock Holding History

IFP Advisors’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.4K Sell
3,756
-10
-0.3% -$186 ﹤0.01% 2102
2026
Q1 		$68.3K Buy
3,766
+3,671
+3,864% +$63.3K ﹤0.01% 2076
2025
Q4 		$1.86K Sell
95
-1
-1% -$19 ﹤0.01% 3868
2025
Q3 		$1.21K Buy
+96
New +$1.09K ﹤0.01% 3876
2025
Q2 		– Hold
0
– – – 3942
2025
Q1 		– Sell
-3
Closed -$71 – 4397
2024
Q4 		$71 Buy
+3
New +$89 ﹤0.01% 4145

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

IFP Advisors's DYN Position: Q2 2026 in Review

IFP Advisors reduced its Dyne Therapeutics (DYN) stake by 0.27% in Q2 2026, selling an estimated $186 and leaving 3,756 shares worth $83.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

IFP Advisors first reported a position in DYN in Q4 2024 and has held it in 5 quarters since. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • IFP Advisors held 3,756 shares of Dyne Therapeutics worth $83.4K as of Q2 2026.
  • IFP Advisors sold 10 Dyne Therapeutics shares in Q2 2026, an estimated $186.
  • Dyne Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2102 holding.
  • IFP Advisors first reported a position in Dyne Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.